health care regulatory publisher HCPro, has launched of Briefings on
Drug Safety, a monthly electronic newsletter that will provide
information and guidance to help pharmaceutical professionals make smart
drug safety, risk management, and marketing decisions.
With thousands of Vioxx-related product liability lawsuits, tighter
oversight by the FDA's new Office of Drug Safety, FDA-mandated risk
management plans and risk communication, and intense Congressional and
media scrutiny, drug safety is in the spotlight more than ever before.
These factors have created an environment in which pre- and
post-approval drug safety, risk management, and risk communications can
make or break a drug.
"The drug safety stakes have never been higher, and that's why drug
safety, regulatory, legal, and marketing professionals in the
pharmaceutical and biotech industries need this newsletter," said David
Beardsley, publisher of Briefings on Drug Safety.
Briefings on Drug Safety is designed to help readers effectively
initiate post-approval safety studies, prepare for rigorous FDA
oversight of drug safety, comply with adverse event reporting
requirements, and design risk management and risk communications plans.
This new launch further expands ePharmaceuticals' line of informational
and training products on regulatory compliance in the life sciences
industries. These products and services take the form of newsletters,
audio conferences, webcasts, training handbooks, e-learning, and on-site
workshops. They cover such topics as drug safety/risk management, Part D
compliance, formulary and reimbursement issues under Medicare Parts B &
D, and marketing innovation.
For more information, including a complimentary copy of Briefings on
Part D Compliance, please visit:
http://www.hcmarketplace.com/prod-4032-EN44013A.html
About ePharmaceuticals
ePharmaceuticals, a division of health care regulatory publisher HCPro,
Inc., provides business intelligence, compliance training, market
research reports and custom publishing services to the pharmaceutical
industry.
Publications include ePharm5, a daily business and marketing innovation
newsletter, Medicare & Reimbursement Advisor Weekly, Briefings on Part D
Compliance, Briefings on Drug Safety, and Pharmaceutical Compliance
Alert.
Our compliance training resources include handbooks, audioconferences,
live workshops, and online learning courses.
###
Press Contact: David Beardsley
Company Name: ePharmaceuticals
Email: email protected from spam bots
Phone: 8774374276
Website: http://www.hcmarketplace.com/prod-4032-EN44013A.html
AndhraNews.net News for May 8, 2006